Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
Biotec - What's the Initial Attraction to Join Silence?
A year and a half ago or so, what was the initial attraction to making that move to join silence? Yes, so back to undervalued assets. I mean, i saw a company that was really in a neat technology space, but also had some a dislocation. So we're kind of in the opposite y sitationa good good when you join silence, as c f l a yo dont w wa, would i say?
Transcript
Play full episode
